Our results showed that the OGN serum level was an independent estimator of impaired kidney function risk in T2D patients by increasing the risk by 8% for a 1 ng/mL increase in the serum OGN regardless of other comorbidities such as CVD or osteoporosis. Here, OGN is linked to osteoporosis.